
University of Cambridge Enterprise
Description
Cambridge Enterprise serves as the commercialization arm of the University of Cambridge, dedicated to helping researchers and academics translate their groundbreaking ideas into tangible societal and economic benefits. Its core mission involves managing intellectual property, providing seed funding, and supporting the creation and growth of spin-out companies from the university's research base. This unique position allows Cambridge Enterprise to identify and nurture early-stage innovations across a broad spectrum of sectors, including life sciences, physical sciences, engineering, and information and communication technologies, reflecting the diverse strengths of the university's research portfolio.
The organization operates several seed funds, including the Cambridge Enterprise Seed Funds and the University of Cambridge Enterprise Fund, which provide crucial early-stage capital to nascent ventures. Beyond direct investment, Cambridge Enterprise plays a pivotal role in connecting these emerging companies with external venture capitalists and strategic partners, facilitating larger follow-on funding rounds. Their investment approach is highly hands-on, often involving active participation in the strategic development of their portfolio companies, leveraging their deep understanding of the underlying technologies and the academic environment.
Cambridge Enterprise boasts a significant track record of success, contributing substantially to the vibrant Cambridge innovation ecosystem. In the fiscal year 2022/23 alone, Cambridge Enterprise invested £10.9 million into 39 companies, demonstrating their active commitment to new ventures. Since its inception, their seed funds have collectively invested over £75 million into more than 200 companies, fostering a robust pipeline of innovation. Furthermore, companies spun out of the University of Cambridge have collectively attracted over £5 billion in follow-on investment over the last decade, underscoring the long-term value and attractiveness of the ventures supported by Cambridge Enterprise.
Investor Profile
University of Cambridge Enterprise has backed more than 102 startups, with 0 new investments in the last 12 months alone. The firm has led 37 rounds, about 36% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom, France, Ireland.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Typical check size: $100K – $500K.
Stage Focus
- Seed (42%)
- Series A (31%)
- Pre Seed (12%)
- Series B (8%)
- Series Unknown (7%)
Country Focus
- United Kingdom (96%)
- France (1%)
- Ireland (1%)
- United States (1%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Life Science
- Medical
- Pharmaceutical
- Information Technology
- Artificial Intelligence (Ai)
- Manufacturing
- Biopharma
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.